business

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

MarketWatch · Jun 9, 2026, 7:37 AM · Also reported by 1 other source

U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.

Read full story on MarketWatch → More top stories

Also covered by

NPR News More Americans survive cancer. But the psychological impacts can persist for years

Aggregated and edited by the Scoop newsroom. We surface news from MarketWatch alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

Also covered by

More in business